María Carpallo-González

María Carpallo-González

Auto-generated profile, based on publicly available information

María Carpallo-González

Faculty of Biomedical and Health Sciences, Department of Psychology, Universidad Europea de Madrid, Madrid, Spain; Department of Personality, Assessment and Psychological Treatments, Faculty of Psychology, Universitat de Valencia, Valencia, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2023 in International Journal of Clinical and Health Psychology
Verified
Journal Article
Open access
MCMaría Carpallo-González
María Carpallo-González
RMRoger Muñoz-Navarro
Roger Muñoz-Navarro
CGCésar González-Blanch
César González-Blanch
ACAntonio Cano-Vindel
Antonio Cano-Vindel
Dropout from psychological treatment is an important problem that substantially limits treatment effectiveness. A better understanding of this phenomenon, could help to minimize it. Therefore, we performed a systematic review of meta-analyses (MA) on dropout from psychological treatments to (1) determine the estimated overall dropout rate (DR) and (2) to examine potential predictors of dropout, including clinical symptoms (anxiety and depression) and sociodemographic factors. A literature search of the PubMed PsycINFO, Embase, Scopus and Google Scholar databases was conducted. We identified 196 MAs on dropout from psychological treatment carried out primarily in adult patients or mixed samples (adults and children) between 1990 and 2022. Of these, 12 met all inclusion criteria. Two forest plots were created to visualize the DR and the relationship between DR and the disorder. The DR ranged from 15.9% to 46.8% and was significantly moderated by symptoms of emotional disorders. The highest DR were observed in younger, unmarried patients, and those with lower educational and income levels. DR in patients undergoing psychological treatment is highly heterogeneous, but higher in individuals presenting symptoms of anxiety and/or depression, especially the latter. Given that high DR undermine the effectiveness of psychological interventions, it is clear that greater efforts are needed to reduce dropout, particularly among individuals with symptoms of emotional disorders.

27 March 2024 in European Psychiatry
Verified
Journal Article
Open access
PDF file
MPMaider Prieto-Vila
Maider Prieto-Vila
CGCésar González-Blanch
César González-Blanch
FEFrancisco J. Estupiñá
Francisco J. Estupiñá
JBJoshua Eusty Jonathan Buckman
Joshua Eusty Jonathan Buckman
RSRob Saunders
Rob Saunders
ACAntonio Cano-Vindel
Antonio Cano-Vindel
There is heterogeneity in the long-term trajectories of depressive symptoms among patients. To date, there has been little effort to inform the long-term trajectory of symptom change and the factors associated with different trajectories. Such knowledge is key to treatment decision-making in primary care, where depression is a common reason for consultation. We aimed to identify distinct long-term trajectories of depressive symptoms and explore pre-treatment characteristics associated with them. A total of 483 patients from the PsicAP clinical trial were included. Growth mixture modeling was used to identify long-term distinct trajectories of depressive symptoms, and multinomial logistic regression models to explore associations between pre-treatment characteristics and trajectories. Four trajectories were identified that best explained the observed response patterns: “recovery” (64.18%), “late recovery” (10.15%), “relapse” (13.67%), and “chronicity” (12%). There was a higher likelihood of following the recovery trajectory for patients who had received psychological treatment in addition to the treatment as usual. Chronicity was associated with higher depressive severity, comorbidity (generalized anxiety, panic, and somatic symptoms), taking antidepressants, higher emotional suppression, lower levels on life quality, and being older. Relapse was associated with higher depressive severity, somatic symptoms, and having basic education, and late recovery was associated with higher depressive severity, generalized anxiety symptoms, greater disability, and rumination. There were different trajectories of depressive course and related prognostic factors among the patients. However, further research is needed before these findings can significantly influence care decisions.

16 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGCésar González-Blanch
César González-Blanch
SBSara Barrio-Martínez
Sara Barrio-Martínez
APAmador Priede
Amador Priede
SMSandra Martínez-Gómez
Sandra Martínez-Gómez
SPSaioa Pérez-García-Abad
Saioa Pérez-García-Abad
ACAntonio Cano-Vindel
Antonio Cano-Vindel
Several randomised controlled trials (RCT) have demonstrated the superiority of transdiagnostic group cognitive-behavioural therapy (TD-CBT) to treatment as usual (TAU) for emotional disorders in primary care. To date, however, no RCTs have been conducted to compare TD-CBT to another active intervention in this setting. Our aim is to conduct a single-blind RCT to compare group TD-CBT plus TAU to progressive muscle relaxation (PMR) plus TAU in adults (age 18 to 65 years) with a suspected emotional disorder. We expect that TD-CBT + TAU will be more cost-effective than TAU + PMR, and that these gains will be maintained at the 12-month follow-up. Seven therapy sessions (1.5 hours each) will be offered over a 24-week period. The study will be carried out at four primary care centres in Cantabria, Spain. The study will take a societal perspective. Psychological assessments will be made at three time points: baseline, post-treatment, and at 12-months. The following variables will be evaluated: clinical symptoms (anxiety, depression, and/or somatic); functioning; quality of life (QoL); cognitive-emotional factors (rumination, worry, attentional and interpretative biases, emotion regulation and meta-cognitive beliefs); and satisfaction with treatment. Data on health service use, medications, and sick days will be obtained from electronic medical records. Primary outcome measures will include: incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICURs). Secondary outcome measures will include: clinical symptoms, QoL, functioning, and treatment satisfaction. Bootstrap sampling will be used to assess uncertainty of the results. Secondary moderation and mediation analyses will be conducted. Two questionnaires will be administered at sessions 1, 4, and 7 to assess therapeutic alliance and group satisfaction. If this trial is successful, widespread application of this cost-effective treatment could greatly improve access to psychological treatment for emotional disorders in the context of increasing demand for mental healthcare in primary care. Trial registration: ClinicalTrials.gov: Cost-effectiveness of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care (PsicAP). NCT05314920.

14 October 2025 in Cognitive Behaviour Therapy
Verified
Journal Article
Open access
GEGabriel Esteller-Collado
Gabriel Esteller-Collado
MPMaider Prieto-Vila
Maider Prieto-Vila
MCMaría Carpallo-González
María Carpallo-González
CACelia Antuña-Camblor
Celia Antuña-Camblor
PRPaloma Ruíz-Rodríguez
Paloma Ruíz-Rodríguez
RNRoger Navarro
Roger Navarro
Anxiety and depressive disorders are the most prevalent disorders worldwide and significantly impair quality of life (QoL). Transdiagnostic cognitive behavioural therapy (TD-CBT) is effective in treating these disorders and improving QoL, but its long-term mechanisms of change are poorly understood. Rumination and worry are key processes addressed by TD-CBT. In this study, we analysed the sequential effect of TD-CBT on post-treatment rumination and worry, anxiety/depression symptoms at 6-months and psychological and physical QoL at 12-months. We use data from PsicAP, a randomised clinical trial in the Primary Care (PC) setting, with 1061 participants randomised to TAU (treatment as usual) or TD-CBT+TAU. Path analyses using SEM were employed to test serial mediation models. Analyses indicated that TD-CBT exerts its long-term beneficial effects on QoL through a cascade of effects, whereby first the maladaptive cognitive processes of rumination and worry are reduced (post-treatment), then anxiety and depressive symptoms (6-months) and finally QoL is improved (12-months). This study provides longitudinal evidence on the mechanisms of change of TD-CBT in patients with anxiety and depression. It also highlights the importance of targeting transdiagnostic interventions towards early modification of negative repetitive thought processes as a critical pathway to long-term symptomatic and functional recovery.

14 June 2023 in Escritos de Psycología / Psychological Writings
Verified
Journal Article
Open access
PDF file
IBIgnacio Cañamero Ballestar
Ignacio Cañamero Ballestar
MGMaría Carpallo González
María Carpallo González
GEGabriel Esteller-Collado
Gabriel Esteller-Collado
RNRoger Navarro
Roger Navarro
Los trastornos de la personalidad están escasamente atendidos en la práctica clínica real, a pesar de que su prevalencia es elevada y causan altas interferencias y malestar emocional en aquellas personas que los padecen. El objetivo de este estudio es llevar a cabo una revisión sistemática sobre el trastorno límite de la personalidad (TLP) y el trastorno histriónico de la personalidad (THP) desde los modelos dimensionales, así como de las estrategias de regulación emocional (RE) empleadas por las personas que padecen estos trastornos. La revisión se ha realizado siguiendo la guía de las normas PRISMA, seleccionando un total de catorce artículos publicados entre el año 2012 y 2022. Los resultados muestran que las personas que sufren TLP son las que presentan mayor gravedad, usan más estrategias de RE desadaptativas y tienen una serie de rasgos patológicos comunes con el THP; mientras, las personas que sufren THP muestran una menor gravedad. Líneas futuras de investigación deberían centrarse en ampliar los estudios sobre los modelos dimensionales y en cómo estos pueden ser una alternativa al diagnóstico categorial tradicional.

10 September 2023 in Behavior Therapy
Verified
Journal Article
Closed access
SBSara Barrio-Martínez
Sara Barrio-Martínez
PRPaloma Ruiz-Rodríguez
Paloma Ruiz-Rodríguez
LMLeonardo Adrián Medrano
Leonardo Adrián Medrano
APAmador Priede
Amador Priede
RNRoger Navarro
Roger Navarro
CGCésar González-Blanch
César González-Blanch